Skip to content

Geron GERN Total Operating Expenses

Total Operating Expenses at other companies

Immunome logo
ImmunomeIMNM
$59.33M+24.7%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$99.07M-4.6%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$151M+0.7%
Celcuity logo
CelcuityCELC
$50.51M+39.8%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$48.77M+1.8%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$53.7M-2.4%

Other financials

Income statement

See full
Revenue$51.8M+30.9%
Operating income$158.0K+101%
Net income-$3.6M+81.6%
EPS (diluted)-$0.01+66.7%

Balance sheet

See full
Cash & equivalents$48.7M-12.2%
Total debt$134.0M+10.0%
Total equity$229.1M-14.6%
Total assets$534.1M-5.0%

Cash flow

See full
Operating cash flow-$62.9M-31.1%
CapEx$206.0K+2.0%
Free cash flow-$43.8M-6.8%

Valuation

See full
Market cap$888.51M-8.6%
Enterprise value$973.78M-6.2%
P/S4.7×-174×

Profitability

See full
Operating margin-705.5%-351pp
Net margin-682.5%-339pp
FCF margin-734.4%-365pp

Returns & leverage

See full
Return on equity-27.1%-7.8pp
Debt / equity0.6×+0.1×
Current ratio6.8×-1.1×

Where this comes from

Reported directly by Geron in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The official record: Geron’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Geron's total operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Geron's total operating expenses?
Geron (GERN) reported total operating expenses of $51.68M in Q1 2026.
How has Geron's total operating expenses changed year-over-year?
Geron's total operating expenses decreased by 8.2% year-over-year, from $56.31M to $51.68M.
What is the long-term trend for Geron's total operating expenses?
Over 4 years (2021 to 2025), Geron's total operating expenses has grown at a 21.6% compound annual growth rate (CAGR), from $115.39M to $252.47M.
What does total operating expenses mean?
The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.